MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0097563
Aprecia Pharmaceuticals Private Limited - business services in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹55.54 Lakh
▲ 16% YoY
Net loss · FY 2024
₹12,191
Net margin -0.2%
EBITDA · FY 2024
-₹3,154
EBITDA margin -0.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Aprecia Pharmaceuticals Private Limited
Data last updated:
Aprecia Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 16 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2017PTC093123. Its GSTIN is 09AAPCA5753N1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Aminabad Surgical Private Limited. It is led by directors Muneeb Alvi and Mohammad Meesam Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 005 Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2024, the company reported a revenue of ₹55.54 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹12,191 (net margin -0.2%) and EBITDA of -₹3,154 (EBITDA margin -0.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 26% over five years.
Aprecia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0097563). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apreciapharma.in.
Company details
CIN U74999UP2017PTC093123
Registration Number 093123
Incorporation Date 16 May 2017
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0097563
Recognitions & Rankings of Aprecia Pharmaceuticals
Contact details
Aprecia Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is apreciapharma.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address005 Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, India – 226001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Aprecia Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aprecia Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aprecia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aprecia Pharmaceuticals Private Limited, buy the company report.
Financials of Aprecia Pharmaceuticals Private Limited
FY 2025 filings availableAprecia Pharmaceuticals Private Limited reported revenue of ₹55.54 Lakh (up 16% YoY) for FY 2024.
Revenue · FY 2024
₹55.54 Lakh ▲ 16%
Net loss · FY 2024
₹12,191 margin -0.2%
EBITDA · FY 2024
-₹3,154 margin -0.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 16%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 98%
3 years · compounded
▼ 27%
5 years · compounded
▲ 48%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 16% growth in the latest year. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3,154 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12,191 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aprecia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aprecia Pharmaceuticals Private Limited
Aprecia Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muneeb Alvi Also directs: Macvision Infrastructure and Developers Private Limited | Director | 16 May 2017 | 9 Years 5 Months | Current |
| Mohammad Meesam Khan | Additional Director | 15 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Aprecia Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Michaels Pharmaceuticals Private Limited | ₹56.08 Lakh (FY 2025) | 36.0% | New Delhi, Delhi, India | |||
| Lifewise Pharmaceuticals Private Limited | ₹55.82 Lakh (FY 2025) | -28.0% | Panchkula, Haryana, India | |||
| Aprecia Pharmaceuticals Private Limitedthis company | ₹55.54 Lakh (FY 2024) | -₹12,191 | -0.2% | 16.0% | Lucknow, Uttar Pradesh, India | |
| Wilfred Pharmaceuticals Private Limited | ₹55.07 Lakh (FY 2025) | 5084.0% | Aurangabad, Maharashtra, India | |||
| Ipsum Pharmaceuticals Private Limited | ₹55.01 Lakh (FY 2021) | -28.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Aprecia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aprecia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aprecia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aprecia Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAPCA5753N1ZW | Uttar Pradesh | Active | 21 Dec 2017 |
To see the full GST registrations and return filing status of Aprecia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aprecia Pharmaceuticals Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Mohammad Asif Khan ceased to be Director on 08 Jan 2024.
AGM
Aprecia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aprecia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Ceased
Mohammad Asif Khan ceased to be Director.
Ceased
Syed Kamran Ahsan ceased to be Director.
Appointed
Mohammad Meesam Khan was appointed as Additional Director.
Ceased
Mohammad Yasir Arafat ceased to be Director.
Appointed
Muneeb Alvi was appointed as Director.
Incorporation
16 May 2017
Aprecia Pharmaceuticals Private Limited was registered on 16 May 2017 with Roc Uttar Pradesh I & aged 9 years 5 months as per MCA records.
Frequently asked questions
Aprecia Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 16 May 2017 (9+ years old) and is registered under CIN U74999UP2017PTC093123.
Aprecia Pharmaceuticals has 2 current directors:
- Muneeb Alvi - Director
- Mohammad Meesam Khan - Additional Director
The latest financial statements of Aprecia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Aprecia Pharmaceuticals is 09AAPCA5753N1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aprecia Pharmaceuticals is U74999UP2017PTC093123. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aprecia Pharmaceuticals was incorporated on 16 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Aprecia Pharmaceuticals by revenue are Michaels Pharmaceuticals Private Limited, Lifewise Pharmaceuticals Private Limited, Wilfred Pharmaceuticals Private Limited, Ipsum Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohammad Asif Khan ceased to be Director on 08 Jan 2024. Syed Kamran Ahsan ceased to be Director on 08 Jan 2024. Mohammad Meesam Khan was appointed as Additional Director on 15 Dec 2023. Aprecia Pharmaceuticals has 5 board changes on record in total.
Yes, Aprecia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0097563).
Aprecia Pharmaceuticals can be reached through the website apreciapharma.in. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Aprecia Pharmaceuticals is at 005 Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, India – 226001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages